Levofloxacina Mylan Generics Italia

Levofloxacin, the active ingredient in Levofloxacina Mylan Generics Italia, is a fluoroquinolone presented as an oral tablet for systemic use. It treats a range of bacterial infections, including urinary tract, respiratory and skin infections, as well as community‑acquired pneumonia and acute bacterial sinusitis, in adult patients when prescribed by a qualified healthcare professional.

GNH USA supplies Levofloxacina Mylan Generics Italia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and procurement teams worldwide, ensuring regulatory‑aligned sourcing and reliable logistics for diverse healthcare settings.

Levofloxacin is a fluoroquinolone antibacterial that targets bacterial DNA replication in various infections.

- Complicated urinary tract infections: eradicates the causative bacteria, helping to resolve infection and prevent recurrence. - Acute bacterial sinusitis: eliminates sinus pathogens, reducing inflammation and restoring normal sinus drainage. - Community‑acquired pneumonia: provides rapid bacterial clearance, improving respiratory function and clinical outcomes. - Acute exacerbations of chronic bronchitis: controls bacterial overgrowth, decreasing symptom severity and duration. - Skin and soft tissue infections: destroys skin‑resident bacteria, facilitating wound healing and infection control. - Prostatitis: penetrates prostatic tissue to suppress bacterial growth, alleviating pain and urinary symptoms.

Levofloxacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Diarrhea: loose stools that may be watery. - Headache: transient cranial discomfort. - Rash: mild skin erythema or itching.

Serious or Rare Side Effects: - Tendon rupture: sudden tendon pain or swelling, especially in the Achilles. - QT interval prolongation: cardiac rhythm disturbances that may cause palpitations. - Severe allergic reactions: anaphylaxis, angioedema, or Stevens‑Johnson syndrome.

Before prescribing levofloxacin, clinicians should consider several safety aspects.

- Assess renal function: dose adjustment may be required in patients with impaired clearance. - Evaluate tendon health: avoid use in patients with recent tendon injury or corticosteroid therapy. - Monitor cardiac status: caution in individuals with known QT prolongation or electrolyte abnormalities. - Review concomitant medications: avoid drugs that may increase the risk of tendon or cardiac events. - Pregnancy and lactation: use only if the potential benefit outweighs the risk, as it is Category C. - Store at ambient temperature: keep below 25°C in the original packaging, protected from moisture and direct sunlight.

Levofloxacin can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: markedly reduce levofloxacin absorption. - Warfarin: may increase anticoagulant effect, raising bleeding risk.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): can increase risk of central nervous system stimulation. - Diabetic agents (e.g., insulin, sulfonylureas): may cause hypoglycemia. - Cyclosporine: levofloxacin may raise cyclosporine levels, requiring monitoring.